论文部分内容阅读
目的探讨心肌梗塞合并心律失常的临床治疗方法及治疗效果。方法选自2013年1月~2015年1月我院收治的心肌梗塞合并心律失常(频发室早,或短发室速未影响血流动力学情况下)患者62例,将其随机分成两组,分别命名为A组和B组。两组患者均给予常规药物治疗的基础上,对A组患者应用胺碘酮,B组患者应用利多卡因。结果 A组患者临床治疗的有效率高于B组患者,治疗期间风险事件的发生率低于B组患者,症状改善时间及出院时间短于B组患者。结论在基础治疗的同时对心肌梗塞并心律失常患者采用胺碘酮治疗能够收到较好的治疗效果,缩短患者的住院时间,有助于促进患者疾病的快速康复。“,”Objective To investigate the clinical treatment of myocardial infarction and arrhythmia treatment. Methods Selected from January 2013 to January 2015 in our hospital myocardial infarction, arrhythmia (frequent PVCs, ventricular tachycardia or short hair - not under the influence of hemodynamics) 62 patients were randomly divided into group 2 were named as group A and group B. Base 2 groups of patients were given conventional therapy on patients A group of amiodarone, lidocaine group B patients. Results A group of clinical patients are more than group B patients, the incidence of treatment during the risk event is less than group B patients, symptoms and discharge time shorter than group B patients. Conclusion While the basic treatment of patients with myocardial infarction and arrhythmia amiodarone can receive better treatment, shorter hospital stay and help promote the rapid rehabilitation of patients the disease.